The U.S. Food and Drug Administration approved DECNUPAZ (pivekimab sunirine-pvzy) for treating adult patients with blastic plasmacytoid dendritic cell neoplasm ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE